These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28092870)

  • 1. Anaplastic variant of plasma cell myeloma with Dutcher bodies.
    Chang H; Kajal B
    Blood; 2016 Jun; 127(25):3291. PubMed ID: 28092870
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions.
    Yamada T; Nannya Y; Mita N; Shimizu M; Seishima M; Tsurumi H
    Int J Hematol; 2016 May; 103(5):483-5. PubMed ID: 26984592
    [No Abstract]   [Full Text] [Related]  

  • 3. Signet-ring plasma cell myeloma.
    Grier DD; Robbins K
    Am J Hematol; 2012 Jun; 87(6):625. PubMed ID: 21953819
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmablastic multiple myeloma with Dutcher bodies.
    Jain D; Singh T
    Indian J Pathol Microbiol; 2008; 51(3):442-3. PubMed ID: 18723987
    [No Abstract]   [Full Text] [Related]  

  • 5. Numerous Russell bodies and Dutcher bodies in multiple myeloma.
    van Gammeren AJ; Alcala LS; Smolders M; Boersma RS
    Br J Haematol; 2015 Sep; 170(6):743. PubMed ID: 25312850
    [No Abstract]   [Full Text] [Related]  

  • 6. Signet ring myeloma: A rare and visually striking entity.
    Manzoor D; Huang Q
    Int J Lab Hematol; 2021 Dec; 43(6):1260-1261. PubMed ID: 33742779
    [No Abstract]   [Full Text] [Related]  

  • 7. Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis.
    Ren Z; Spaargaren M; Pals ST
    Blood; 2021 Apr; 137(13):1713-1718. PubMed ID: 33512430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An old misconception: Dutcher bodies are intranuclear inclusions in plasma cells?
    Han JH; Cho SR
    Leuk Lymphoma; 2019 Jan; 60(1):265-267. PubMed ID: 29846124
    [No Abstract]   [Full Text] [Related]  

  • 9. CD138
    Shuai W; Li S
    Blood; 2019 Sep; 134(11):906. PubMed ID: 31515228
    [No Abstract]   [Full Text] [Related]  

  • 10. Seemingly insignificant, but crucial morphological leads in the diagnosis of non-secretory multiple myeloma in an adolescent.
    Mishra J; Chopra A; Gogia A; Kumar R
    Indian J Pathol Microbiol; 2012; 55(1):130-2. PubMed ID: 22499328
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematologists usually over-estimate the percentage of CD138+ plasma cells in marrow biopsies.
    Chai KY; Boyke Berahmana AA; Morison IM
    Pathology; 2019 Oct; 51(6):647-648. PubMed ID: 31470997
    [No Abstract]   [Full Text] [Related]  

  • 12. The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma.
    Warnnissorn AN; Treetipsatit J; Limvorapitak W
    Hematology; 2020 Dec; 25(1):292-298. PubMed ID: 32772824
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating plasma cells with Russell bodies in osteosclerotic myeloma.
    Chen M; Green R
    Blood; 2013 Jul; 122(2):160. PubMed ID: 24006527
    [No Abstract]   [Full Text] [Related]  

  • 14. Robust isolation of malignant plasma cells in multiple myeloma.
    Frigyesi I; Adolfsson J; Ali M; Christophersen MK; Johnsson E; Turesson I; Gullberg U; Hansson M; Nilsson B
    Blood; 2014 Feb; 123(9):1336-40. PubMed ID: 24385542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
    Abdalla S; May PC; Garimberti E; Naresh KN
    Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of 14q32 rearrangements in multiple myeloma, using simultaneous FISH analysis combined with immunofluorescence.
    Abaza HM; Youssef SR; Saad AA; Kamal GM; Hegazy MG; Ibrahim RI; Annaka LM
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):56-63. PubMed ID: 25929730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple myeloma].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117
    [No Abstract]   [Full Text] [Related]  

  • 18. Dutcher bodies in IgA multiple myeloma.
    Martino G; Zanelli M; Zizzo M; Ricci L; Ascani S
    Ann Hematol; 2020 Sep; 99(9):2205-2206. PubMed ID: 32705307
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of histidine decarboxylase as a marker of malignant transformation and dedifferentiation of B-cells infiltrating the skin. A case report of a therapy-resistant multiple myeloma complicated by skin infiltration.
    Varkonyi J; Karádi I; Szocs K; Sugár I; Sápi Z; Marschalko M; Pállinger E; Darvas Z; Falus A
    Acta Oncol; 2008; 47(3):458-61. PubMed ID: 17851872
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlations between karyotype and cytologic findings in multiple myeloma.
    Weh HJ; Bartl R; Seeger D; Selbach J; Kuse R; Hossfeld DK
    Leukemia; 1995 Dec; 9(12):2119-22. PubMed ID: 8609726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.